|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
EDC just went ex-growth 
Well, not quite, but almost if you listen to Phase.
BITI, sorry BIOC, already said imaging went ex-growth,
which was why they tried to buy etrials. Kinda offsets
the nice win...
Business & Finance > Investments > Stocks (A to Z) > Stocks B >
BioClinica, Inc.
|
|
culleraa |
|
5-Feb-10 09:11 am |
| |
| 2. |
Re: Mediation...
Got to remember Barry gets paid to be an optimist,
but: Caldwell said "If mediation fails, Staar
can file another bond of $10 million, which Caldwell
says Staar can raise. "We...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
STAAR Surgical Company
|
|
culleraa |
|
4-Feb-10 06:21 am |
| |
| 3. |
Re: Company web site, no financials
And remember, the company has NOT said it will have
a cc. OR PR on earnings, or lack of. Probably have
to wait til Mar 16 like last year...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Otix Global, Inc.
|
|
culleraa |
|
2-Feb-10 01:36 pm |
| |
| 4. |
Re: "Million"-dollar contract
At $1.875 per patient per month, Data can make a profit
with 80% margin. I'd bet Phase can't. Maybe
this is the strategy? Knock the price down and do
what Nokia did to Motorola!
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DATATRAK International, Inc.
|
|
culleraa |
|
2-Feb-10 09:44 am |
| |
| 5. |
Re: Japan ICL approval, PR 2 Feb 2010, 0800 EST
This is a very strong endorsement from Shimadzu. He
has over 200 papers co-authored and published in English...
and he has no commercial ties to Staar. The...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
STAAR Surgical Company
|
|
culleraa |
|
2-Feb-10 09:20 am |
| |
| 6. |
"Million"-dollar contract
If only some 100K this year, unless they can recognize
upfront. A lot can happen in 8 years!
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DATATRAK International, Inc.
|
|
culleraa |
|
1-Feb-10 07:44 am |
| |
| 7. |
Mediation...
"Only" took 2 months to get this far! Another
two months and we should know. Moody does not want
to risk losing the appeal, perhaps? A case of if its
not bad news it...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
STAAR Surgical Company
|
|
culleraa |
|
1-Feb-10 06:57 am |
| |
| 8. |
130 million gone, so how much more
Interesting situation here. Company needs at least
2 years I would think to get a years data for submission.
That equates to some 50 m net expense minimum, at
...
Business & Finance > Investments > Stocks (A to Z) > Stocks E >
EnteroMedics, Inc. (ETRM)
|
|
culleraa |
|
1-Feb-10 06:36 am |
| |
| 9. |
Re: Good earnings
Post ipo lows indicates no support... either due to
lack of Caldolor sell-through to hospitals or... the
opening of the usual insider sells window 6-month
post ipo. Not sure if they...
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cumberland Pharmaceuticals, Inc. (CPIX)
|
|
culleraa |
|
1-Feb-10 06:21 am |
| |
| 10. |
Re: Looking better...
Given the cash generation, which reflects two things:
new ERP and hosp's ability to pay... and the revenue
run rate, then Omnicell is selling for an EV of 1x
sales again right...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Omnicell Inc. (OMCL)
|
|
culleraa |
|
29-Jan-10 01:04 pm |
| |
| 11. |
Looking better...
... but have to wait. Since it is a backlog business,
earlier by design - now by necessity!- takes a long
time before we see the results. In the meantime, cash
went up dramatically. EBITDA...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
Omnicell Inc. (OMCL)
|
|
culleraa |
|
29-Jan-10 07:01 am |
| |
| 12. |
Re: Gotta love a stock that makes a...
Yeah, well at an EV:sales ratio of sub 2, it is cheap
for the sector. Even EV=2 equals $20 a share, given
the cash. Could easily be up much higher. Jan seems
confident...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AngioDynamics, Inc. (ANGO)
|
|
culleraa |
|
20-Jan-10 03:45 pm |
| |
| 13. |
Re: Annual report
... well cos SEC filing is obligatory..well, if you
want to be listed! Real question is why it takes so
long to tel us Sept sales, when mgmt knows Dec sa
les...
Business & Finance > Investments > Stocks (A to Z) > Stocks T >
Trimedyne, Inc.
|
|
culleraa |
|
17-Jan-10 03:42 pm |
| |
| 14. |
Jp Morgan
One of the last slots given! Jan really needs to develop
his pitch to these folk though. Basically, the story
comes off as we have a wide range of stuff, and a
wide range of ways...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AngioDynamics, Inc. (ANGO)
|
|
culleraa |
|
15-Jan-10 06:23 am |
| |
| 15. |
Re: Court Grants Endologix&&39;s Motion to Stay Patent Litigation
Let's hope it's a case of what doesn't
kill, makes you stronger! Last time we reached these
levels this year, the joy lasted for two weeks...
here's...
Business & Finance > Investments > Stocks (A to Z) > Stocks E >
Endologix Inc. (ELGX)
|
|
culleraa |
|
13-Jan-10 04:07 pm |
| |
| 16. |
Fireside chats today in NYC
By invitation only... shame
Business & Finance > Investments > Stocks (A to Z) > Stocks I >
IRIS International, Inc. (IRIS)
|
|
culleraa |
|
13-Jan-10 10:40 am |
| |
| 17. |
Half the story
Or less. Well its nice the backlog is up, as long as
there was good billing, = revenue, as well in the
final quarter. Datatrack is still a significant small
EDC player... but there are many other...
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DATATRAK International, Inc.
|
|
culleraa |
|
13-Jan-10 08:16 am |
| |
| 18. |
Re: January 2010 presentation as part of their filing...
Many bought into this technology promise, BUT only
the financing and its terms count. Actually, anyone
else's investment but LFB's is welcome, even
at this price. LFB (cheap) debt...
Business & Finance > Investments > Stocks (A to Z) > Stocks G >
GTC Biotherapeutics, Inc.
|
|
culleraa |
|
11-Jan-10 10:03 am |
| |
| 19. |
Re: Going To $0.30 per Share?
Volume! Well, like this they can clear the shares in
an orderly fashion. 1 m in five days. Remembering
dimly now the founders lost a proxy fight a year ago
and sold sub...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VirtualScopics Inc. (VSCP)
|
|
culleraa |
|
8-Jan-10 03:04 pm |
| |
| 20. |
Many positives + a negative
Positive: Did we all notice Newberry was not on the
release... a cost saving? Positive that this was not
"said by" Cox: alpha-fetoprotein program
into a Phase II study in Myasthenia Gravis in the
...
Business & Finance > Investments > Stocks (A to Z) > Stocks G >
GTC Biotherapeutics, Inc.
|
|
culleraa |
|
8-Jan-10 02:52 pm |
| |
